Align
Invisalign Itero

Biography

<< Back
Kevin

Kevin Conroy

Independent Director

Elected

Experience:  
2009 - Present CEO and Chairman of the Board (2014), Exact Sciences
  Corp. (molecular diagnostics company) 
2005 - 2008 President and CEO, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
2004 - 2005 General Counsel, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
Prior Various Leadership Positions at GE Healthcare
  (medical technology company) 

Other Board Positions
Adaptive Biotechnologies Corporation (2019-2023)
Epizyme, Inc. (2017-2022)
CM Life Sciences II Inc. (2021)
SomaLogic, Inc. (2021)
Arya Sciences Acquisition Corp. (2018-2020)

Notable Experience and Key Board Contributions

  • Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries.
  • At Exact Sciences, Mr. Conroy has developed Cologuard and the company has grown to $2.5B in revenue while serving 4 million patients.
  • At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients.

Education
B.S. in Electrical Engineering from Michigan State University
J.D. from the University of Michigan Law School

 

Minimum 15 minutes delayed. Source: LSEG